Pms1077 Sensitizes Tnf-Alpha Induced Apoptosis In Human Prostate Cancer Cells By Blocking Nf-Kappa B Signaling Pathway

Jie Shi,Jing Chen,Nawal Serradji,Ximing Xu,Heng Zhou,Yinxing Ma,Zhihong Sun,Peng Jiang,Yuping Du,Jinbo Yang,Changzhi Dong,Qin Wang
DOI: https://doi.org/10.1371/journal.pone.0061132
IF: 3.7
2013-01-01
PLoS ONE
Abstract:Our previous studies have demonstrated that PMS1077, a platelet-activating factor (PAF) antagonist, could induce apoptosis of Raji cells. However, the mechanism of action has not yet been determined. The nuclear transcription factor-kappa B (NF-kappa B) signaling pathway plays a critical role in tumor cell survival, proliferation, invasion, metastasis, and angiogenesis, so we determined the effects of PMS1077 and its structural analogs on tumor necrosis factor-alpha (TNF-alpha) induced activation of NF-kappa B signaling. In this study, we found that PMS1077 inhibited TNF-alpha induced expression of the NF-kappa B regulated reporter gene in a dose dependent manner. Western blot assay indicated that PMS1077 suppressed the TNF-alpha induced inhibitor of kappa B-alpha (I kappa B alpha) phosphorylation, I kappa B-alpha degradation, and p65 phosphorylation. PMS1077 consistently blocked TNF-alpha induced p65 nuclear translocation as demonstrated in the immunofluorescence assay used. Docking studies by molecular modeling predicted that PMS1077 might interact directly with the I kappa B kinase-beta (IKK-beta) subunit. These results suggested that PMS1077 might suppress the activation of NF-kappa B by targeting IKK-beta involved in the NF-kappa B signaling pathway. Finally, we showed that PMS1077 sensitized cells to TNF-alpha induced apoptosis by suppressing the expression of NF-kappa B regulated anti-apoptotic genes. Our results reveal a novel function of PMS1077 on the NF-kappa B signaling pathway and imply that PMS1077 can be considered as an anti-tumor lead compound.
What problem does this paper attempt to address?